DavidMWeinreichMD

PubMed

• 1 citations
  Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large clai...
  Mohamed Hussein, Wenhui Wei, Vera Mastey, Robert J Sanchez, Degang Wang, Dana J Murdock, Boaz Hirshberg, David M Weinreich, Jessica J Jalbert> ;BMJ Open. 2022 Dec 19
• 2 citations
  Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline...
  Andrea T Hooper, Selin Somersan-Karakaya, Shane E McCarthy, Eleftherios Mylonakis, Shazia Ali, Jingning Mei, Rafia Bhore, Adnan Mahmood, Gregory P Geba, Paula Dakin, D...> ;Mbio. 2022 Dec 20
• 2 citations
  Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19.
  Jessica J Jalbert, Mohamed Hussein, Vera Mastey, Robert J Sanchez, Degang Wang, Dana Murdock, Laura Fariñas, Jonathan Bussey, Carlos Duart, Boaz Hirshberg, David M Wei...> ;Infectious Diseases and Therapy. 2022 Dec 1
• 39 citations
  Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
  Amy S Paller, Eric L Simpson, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Weily Soong, Mercedes E Gonzalez, Lynda C Schneider, Robert Si...> ;Lancet. 2022 Sep 17
• 8 citations
  Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
  Patel, B. C., Wilson, C. N., Baddley, J. W., Patel, B. C., Portal-Celhay, C., Forleo-Neto, E., Eagan, W., Musser, B., Davis, J., Turner, K., Norton, T., Hooper, A., Ha...> ;JAMA Network Open. 2022 Aug 1
• 12 citations
  Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled...
  Gary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kuo-Chen Chan, Katharine J Bar, Ruanne V Barnabas, Dan H Barouch, Myron S C...> ;The Lancet. Infectious Diseases. 2022 Oct 1
• 9 citations
  Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
  Flonza Isa, Eduardo Forleo-Neto, Jonathan Meyer, Wenjun Zheng, Scott Rasmussen, Danielle Armas, Masaru Oshita, Cynthia Brinson, Steven Folkerth, Lori Faria, Ingeborg H...> ;International Journal of Infectious Diseases. 2022 Sep 1
• 125 citations
  Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
  Michael E. Wechsler, Marcella Ruddy, Ian D. Pavord, Elliot Israel, Klaus F. Rabe, Linda B. Ford, Jorge Maspero, Raolat M Abdulai, Chih-Chi Hu, Renata Martincova, Andre...> ;The New England Journal of Medicine. 2021 Oct 28
• 378 citations
  REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
  David M. Weinreich, Sumathi Sivapalasingam, Thomas T. Norton, Shazia Ali, Haitao Gao, Rafia Bhore, Jing Xiao, Andrea T. Hooper, Jennifer D. Hamilton, Bret J. Musser, D...> ;The New England Journal of Medicine. 2021 Sep 29
• 60 citations
  Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
  David M. Brown, Charles C. Wykoff, David S. Boyer, Jeffrey S. Heier, W. Lloyd Clark, Andres Emanuelli, Patrick M. Higgins, Michael C. Singer, David M. Weinreich, Georg...> ;JAMA Ophthalmology. 2021 Sep 1
• 51 citations
  Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial.
  Klaus F. Rabe, Bartolome R. Celli, Michael E. Wechsler, Raolat M Abdulai, Xiaodong Luo, Maarten M Boomsma, Heribert Staudinger, Julie E. Horowitz, Aris Baras, Manuel A...> ;The Lancet. Respiratory Medicine. 2021 Jul 21
• 19 citations
  Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention
  Meagan P. O'Brien, Eduardo Forleo Neto, Bret J Musser, Flonza Isa, Kuo-Chen Chan, Neena Sarkar, Katharine J. Bar, Ruanne V. Barnabas, Dan H. Barouch, Myron S. Cohen, C...> ;Medrxiv. 2021 Jun 17
• 9 citations
  Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection
  Meagan P. O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kuo-Chen Chan, Bret J Musser, Katharine J. Bar, Ruanne V. Barnabas, Dan H. Barouch, Myron...> ;Medrxiv. 2021 Jun 14
• 28 citations
  Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a phase 1 study
  Philippe Gevaert, Jarno De Craemer, Natalie De Ruyck, Sylvie Rottey, Jan de Hoon, Peter Hellings, Bram Volckaert, Kristof Lesneuck, Jamie M. Orengo, Amanda Atanasio, M...> ;The Journal of Allergy and Clinical Immunology. 2021 Jun 11
• 129 citations
  Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
  Alexander J. Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Martin Kaatz, Karl D. Lewis, Nicole Basset-Seguin, Anne Lynn S. Chang, Stéphane ...> ;The Lancet. Oncology. 2021 Jun 1
• 14 citations
  Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial
  Paula Dakin, Alan Kivitz, Joseph Gimbel, Stephen J. DiMartino, Chetachi Emeremni, Haitao Gao, Neil Stahl, David M. Weinreich, George D. Yancopoulos, Gregory P. Geba> ;Annals of the Rheumatic Diseases. 2021 Apr 1
• 3 citations
  Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV).
  Sumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, Aya Nakamura, Thomas Conrad, Mohamed Hassanein, Giane Sumner, Chinnasamy Elango, Mohamed A. Kamal, Simon ...> ;The Journal of Infectious Diseases. 2021 Jan 28
• 1125 citations
  REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
  David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton, Shazia Ali, Haitao Gao, Rafia Bhore, Bret J Musser, Yuhwen Soo, Diana Rofail, Joseph Im, Christina Perry, Cy...> ;The New England Journal of Medicine. 2021 Jan 21
• 126 citations
  The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
  Richard Copin, Alina Baum, Elzbieta Wloga, Kristen E. Pascal, Stephanie Giordano, Benjamin O. Fulton, Anbo Zhou, Nicole Negron, Kathryn Lanza, Newton Chan, Angel Coppo...> ;Cell. 2021 Jan 1
• 154 citations
  Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, pl...
  Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J. Cork, Peter D. Arkwright, Melinda Gooderham, Lisa A. Beck, Mark Boguniewicz, Lawrence...> ;Journal of the American Academy of Dermatology. 2020 Nov 1
• 66 citations
  Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
  Eric A. F. Simões, Eduardo Forleo-Neto, Gregory P. Geba, Mohamed A. Kamal, Feng Yang, Helen Cicirello, Matthew R Houghton, Ronald Rideman, Qiong Zhao, Sarah L Benvin, ...> ;Clinical Infectious Diseases. 2020 Sep 8
• 2 citations
  Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
  Eric D. Bateman, Asif Khan, Yingxin Xu, Patricia Guyot, Jingdong Chao, Siddhesh Kamat, Paul Rowe, Heather F. Burnett, Jerome Msihid, David M. Weinreich, Ian D. Pavord> ;Respiratory Medicine. 2020 Aug 5
• 14 citations
  Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma
  Eric D. Bateman, Asif Khan, Yingxin Xu, Patricia Guyot, Jingdong Chao, Siddhesh Kamat, Paul Rowe, Heather F. Burnett, Jerome Msihid, David M. Weinreich, Ian D. Pavord> ;Respiratory Medicine. 2020 Apr 29
• 24 citations
  Association of High Serum Interleukin‐6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimum...
  Anita Boyapati, Sergio Schwartzman, Jerome Msihid, Ernest Choy, Mark C. Genovese, Gerd R Burmester, Gordon K Lam, Toshio Kimura, Jonathan Sadeh, David M. Weinreich, Ge...> ;Arthritis & Rheumatology. 2020 Apr 28
• 245 citations
  Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
  Michael R. Migden, Nikhil I. Khushalani, Anne Lynn S. Chang, Karl D. Lewis, Chrysalyne D. Schmults, Leonel Hernandez-Aya, Friedegund Meier, Dirk Schadendorf, Alexander...> ;The Lancet. Oncology. 2020 Feb 1
• Join now to see all

Journal Articles

• REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19  
  David Weinreich, MD, The New England Journal of Medicine

Abstracts/Posters

• Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
  David M. Weinreich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
  David M. Weinreich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019